** Shares of medical device maker Dynatronics Corporation
DYNT.O fall 10.4% at $2.41
** Co reported Q2 2023 per share loss of 27 cents vs
analysts' expectations for a loss of 15 cents/shr - Refinitiv
** DYNT, however, reported an increase in revenue to $10.88
mln from $10.53 mln in the same quarter last year
*** Co reaffirmed net sales guidance for fiscal year 2023 of
$45 mln to $48 mln
** DYNT continues to expect volatility due to the challenges
related to the broader economic environment and the COVID-19
global pandemic
** All 3 brokerages covering the stock rate it "buy" or
higher; median PT is $11.25 - Refinitiv data
** In 2022, co's stock fell nearly 61%
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))